Literature DB >> 9089953

HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication.

C Jassoy1, B D Walker.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9089953     DOI： 10.1007/BF00813502

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  100 in total

1.  CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual.

Authors:  C E Mackewicz; H W Ortega; J A Levy
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

2.  High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals.

Authors:  F M Gotch; D F Nixon; N Alp; A J McMichael; L K Borysiewicz
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

3.  Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.

Authors:  T Harrer; E Harrer; S A Kalams; P Barbosa; A Trocha; R P Johnson; T Elbeik; M B Feinberg; S P Buchbinder; B D Walker
Journal:  J Immunol       Date:  1996-04-01       Impact factor: 5.422

4.  Immunophenotypic characterization of the cutaneous exanthem of SIV-infected rhesus monkeys. Apposition of degenerative Langerhans cells and cytotoxic lymphocytes during the development of acquired immunodeficiency syndrome.

Authors:  D J Ringler; W W Hancock; N W King; N L Letvin; M D Daniel; R C Desrosiers; G F Murphy
Journal:  Am J Pathol       Date:  1987-02       Impact factor: 4.307

5.  Simian immunodeficiency virus-specific cytotoxic T lymphocytes are present in the AIDS-associated skin rash in rhesus monkeys.

Authors:  H Yamamoto; D J Ringler; M D Miller; Y Yasutomi; T Hasunuma; N L Letvin
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

6.  Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo.

Authors:  J A Byrne; M B Oldstone
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

7.  Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid.

Authors:  S S Frankel; B M Wenig; A P Burke; P Mannan; L D Thompson; S L Abbondanzo; A M Nelson; M Pope; R M Steinman
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

8.  Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled.

Authors:  R M Zinkernagel; A Althage
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

9.  Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast.

Authors:  K Falk; O Rötzschke; K Deres; J Metzger; G Jung; H G Rammensee
Journal:  J Exp Med       Date:  1991-08-01       Impact factor: 14.307

10.  Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.

Authors:  M R Klein; C A van Baalen; A M Holwerda; S R Kerkhof Garde; R J Bende; I P Keet; J K Eeftinck-Schattenkerk; A D Osterhaus; H Schuitemaker; F Miedema
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307
View more
  9 in total

1.  Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.

Authors:  S I Staprans; P J Dailey; A Rosenthal; C Horton; R M Grant; N Lerche; M B Feinberg
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 2.  Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Authors:  K Ikuta; S Suzuki; H Horikoshi; T Mukai; R B Luftig
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

Review 3.  Virus and target cell evolution in human immunodeficiency virus type 1 infection.

Authors:  D E Mosier
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

4.  Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.

Authors:  E J Verschoor; P Mooij; H Oostermeijer; M van der Kolk; P ten Haaft; B Verstrepen; Y Sun; B Morein; L Akerblom; D H Fuller; S W Barnett; J L Heeney
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice.

Authors:  G T Belz; P G Stevenson; M R Castrucci; J D Altman; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

6.  The Role of the Envelope Glycoprotein in the Depletion of T Helper Cells in Human Immunodeficiency Virus Infection.

Authors:  Christian Jassoy; Martin Heinkelein; Sieghart Sopper
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

7.  Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection.

Authors:  Brett D Shepard; Mona R Loutfy; Janet Raboud; Frank Mandy; Colin M Kovacs; Christina Diong; Michele Bergeron; Victoria Govan; Stacey A Rizza; Jonathan B Angel; Andrew D Badley
Journal:  J Acquir Immune Defic Syndr       Date:  2008-06-01       Impact factor: 3.731

8.  Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity.

Authors:  Aviva Joseph; Jian Hua Zheng; Antonia Follenzi; Teresa Dilorenzo; Kaori Sango; Jaime Hyman; Ken Chen; Alicja Piechocka-Trocha; Christian Brander; Erik Hooijberg; Dario A Vignali; Bruce D Walker; Harris Goldstein
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

Review 9.  Cytotoxic T-lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo?

Authors:  P Borrow; G M Shaw
Journal:  Immunol Rev       Date:  1998-08       Impact factor: 12.988
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.